2000
DOI: 10.1378/chest.117.2.447
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of CO2 Retention in Patients With Neuromuscular Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
45
0
1

Year Published

2003
2003
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(51 citation statements)
references
References 28 publications
(52 reference statements)
4
45
0
1
Order By: Relevance
“…1B, C and D To investigate whether the CVrr is useful for estimating hypercapnia in DMD patients, we classified the patients according to the CVrr and hypercapnia (Table 3). Here, we defined "hypercapnia" as PaCO2 greater than 45 mmHg (1,9), and "severe hypercapnia" as PaCO2 greater than 50 mmHg. We usually use the latter value as a critical respiratory failure, and if a patient shows this value, we should consider further respiratory support (1,10).…”
Section: Methodsmentioning
confidence: 99%
“…1B, C and D To investigate whether the CVrr is useful for estimating hypercapnia in DMD patients, we classified the patients according to the CVrr and hypercapnia (Table 3). Here, we defined "hypercapnia" as PaCO2 greater than 45 mmHg (1,9), and "severe hypercapnia" as PaCO2 greater than 50 mmHg. We usually use the latter value as a critical respiratory failure, and if a patient shows this value, we should consider further respiratory support (1,10).…”
Section: Methodsmentioning
confidence: 99%
“…4 In patients with NMDs, the reduction of inspiratory and/or expiratory muscle strength is thus related to ineffective alveolar ventilation and difficult airway clearance, which lead to increased risk of developing atelectasis, pneumonia and chronic respiratory insufficiency. [7][8][9] Therefore, the assessment of absolute and relative inspiratory and expiratory muscle impairment is of high clinical relevance. Veale et al 6 found a significant difference between P Imax and P Emax values in subjects with NMDs, namely facio-scapulo humoral dystrophy, limb girdle dystrophy, spinal muscular atrophy, mitochondrial myopathy, and polymyositis.…”
Section: Introductionmentioning
confidence: 99%
“…Some LGMD patients, however, experience chronic cough, dyspnoea on exertion, recurrent respiratory tract infections and signs of alveolar hypoventilation [10]. In BMD, cardiac involvement is the dominant feature and respiratory insufficiency is only rarely reported [11][12][13]. In FSHD pulmonary dysfunction tends to be mild and frequently associated with obstructive sleep apnea related to upper airway muscle weakness [14][15][16][17].…”
Section: Introductionmentioning
confidence: 99%